Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Muscle Protein Synthesis Rates After Protein Consumption in Lean, Overweight, and Obese Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02613767
Recruitment Status : Completed
First Posted : November 24, 2015
Last Update Posted : October 26, 2016
Sponsor:
Information provided by (Responsible Party):
Nicholas Burd, University of Illinois at Urbana-Champaign

Tracking Information
First Submitted Date November 5, 2015
First Posted Date November 24, 2015
Last Update Posted Date October 26, 2016
Study Start Date December 2014
Actual Primary Completion Date September 2015   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: November 20, 2015)
Fractional synthetic rate of myofibrillar proteins [ Time Frame: 7 hours ]
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Muscle Protein Synthesis Rates After Protein Consumption in Lean, Overweight, and Obese Adults
Official Title Muscle Protein Synthesis Rates After Protein Consumption in Lean, Overweight, and Obese Adults
Brief Summary There are an increasing number of individuals in the United States with obesity, and this is a major health concern with links to many chronic diseases. Impairments in protein metabolism with obesity may disrupt muscle function and modify the dietary protein requirements in obese individuals. Further, overweight and obese type 2 diabetics exhibit dramatically reduced skeletal muscle mass compared with lean, healthy controls. Surprisingly, the influence of being overweight or obese on this decline in muscle mass remains understudied, despite clear evidence that similar metabolic impairments typically exist in these populations prior to the development of overt diabetes. Protein ingestion provides the amino acid building blocks to synthesize and repair muscle proteins in adults. Previous research has shown that the muscle protein synthetic response to food ingestion may be reduced in overweight/obese adults. However, this research provided the 'free' amino acids in small portions every 15 min during the postprandial period. In free living conditions, however, it is more common to consume protein dense foods in single portions. Currently, there is no information available on how eating protein rich foods affects muscle protein synthesis in overweight and obese adults. This proposed research will fill this research gap by being the first study to compare the muscle protein synthetic response to the ingestion of a meal-like amount of high quality protein in lean, overweight and obese adults. The objective of this study is to determine the muscle protein synthetic response after the consumption of 35g pork protein in lean, overweight and obese adults. In order to assess this objective the researchers propose to use primed continuous infusion of L-[ring-13C6] phenylalanine to measure muscle protein synthesis rates after the consumption of dietary protein. In a parallel design the researchers will study 13 obese (BMI 30-39.9 kg/m2) participants, 13 overweight (BMI 25-29.9 kg/m2), and 13 age-matched lean controls (BMI 18-24.9 kg/m2) between the ages of 20 and 45 years. All subjects will be sedentary and weight stable for the previous 6 months. On the test day, subjects will remain sedentary for the determination of muscle protein synthesis in both the fasted state and after consumption of the protein meal. Blood and muscle sampling will occur on the test day.
Detailed Description Participants will be asked to report to the laboratory at 7:00 am following an overnight fast. Upon arrival, a Teflon catheter will be inserted in an antecubital vein of one arm for arterialized blood sampling and a baseline blood sample will be drawn. Arterialized blood samples will be obtained by wrapping the subjects' forearm in a heating blanket (45 °C) for 10 min prior to each blood collection time point. A second Teflon catheter will be inserted in an antecubital vein of the opposite arm, and participants will receive a priming dose of L-[ring- 13C6]phenylalanine (2.0 µmol∙kg) prior to initiating a continuous infusion of L-[ring-13C6]phenylalanine (0.05 µmol∙kg∙min) (t=-240). The prime and continuous tracer infusion will be passed through a 0.2 μm filter. Blood will be collected every 1 hour and biopsies of the vastus lateralis will be collected at t=-180 and t=-15 min using a 5 mm Bergström needle (modified for manual suction) under 2% xylocaine local anesthesia for the measurement of postabsorptive muscle protein synthesis rates. The second biopsy (t=-15 min) will be used to determine baseline levels of phosphorylated and total proteins involved in nutrient sensing and muscle anabolic signaling. Subsequently, the participants will ingest 6 oz of fresh ground center cut pork loin. This cut of meat was selected due to its low lipid content (2.5-3%) and it is uniform in shape, size and composition. Along with the ingested pork, the participants will consume 300 mL of water. The water will be enriched to 5% with tracer according to the phenylalanine content of ~4% in the pork. This approach is required to minimize disturbances in isotopic steady state and provide appropriate conditions for the calculation of postprandial muscle protein synthesis rates. The time required to consume the pork will be recorded. The completion of the pork meal and water will mark the start of the postprandial phase (t=0). During this period, arterialized blood samples will be collected into evacuated chilled heparinized tubes at t=30, 60, 90, 120, 180, 240, and 300 min. Additional muscle biopsies will be collected at t=120 and 300 min of the experimental infusion for the measurement of postprandial muscle protein synthetic and muscle anabolic signaling protein responses. The muscle biopsy samples will be freed from any visible blood, fat, and connective tissue, rapidly frozen in liquid nitrogen and stored at -80˚C until analysis. Blood samples will be centrifuged at 1,000×g at 4˚C for 10 min and separated plasma will be transferred to 2.0 ml cryovials. The plasma samples will be stored at -20˚C until further analysis.
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Retention:   Samples Without DNA
Description:
Plasma samples and Skeletal muscle tissue
Sampling Method Non-Probability Sample
Study Population We recruited 32 healthy, sedentary adult subjects (20-45 y) for this investigation. There are three groups being studied, which will be stratified by body mass index. Because randomization is not possible, groups were balanced by age and sex. No races or ethnic groups will be specifically recruited or excluded.
Condition Obesity
Intervention
  • Other: Protein meal
    Ingestion of protein
  • Other: L-[ring 13C6]Phenylalanine infusion
    experimental method for determining protein synthesis rates
Study Groups/Cohorts
  • Obese

    BMI >30 kg/m2, Protein meal,

    L-[ring 13C6]Phenylalanine infusion

    Interventions:
    • Other: Protein meal
    • Other: L-[ring 13C6]Phenylalanine infusion
  • Overweight

    BMI >25 and < 30 kg/m2, Protein meal,

    L-[ring 13C6]Phenylalanine infusion

    Interventions:
    • Other: Protein meal
    • Other: L-[ring 13C6]Phenylalanine infusion
  • Healthy-Weight

    BMI >18 and < 25 kg/m2, Protein meal,

    L-[ring 13C6]Phenylalanine infusion

    Interventions:
    • Other: Protein meal
    • Other: L-[ring 13C6]Phenylalanine infusion
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: November 20, 2015)
32
Original Actual Enrollment Same as current
Actual Study Completion Date August 2016
Actual Primary Completion Date September 2015   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Males and Females
  • Aged between 20-45 years
  • Healthy, sedentary
  • Three groups, age and sex matched
  • Healthy weight group: BMI 18-24.9 kg/m2
  • Overweight group: BMI 25-29.9 kg/m2
  • Obese group: BMI 30-39.9 kg/m2

Exclusion Criteria:

  • Smoking
  • Allergies to pork consumption
  • Unusually high protein consumption
  • Vegetarians
  • Phenylketonuria (PKU)
  • Diagnosed GI tract diseases
  • Arthritic conditions
  • A history of neuromuscular problems
  • Previous participation in amino acid tracer studies
  • Predisposition to hypertrophic scarring or keloid formation
  • Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
  • Irregular menstrual cycles during the previous year
  • Pregnancy
  • High BMI that is not representative of being overweight or obese (e.g. resistance trained individuals, football players)
Sex/Gender
Sexes Eligible for Study: All
Ages 20 Years to 45 Years   (Adult)
Accepts Healthy Volunteers Yes
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number NCT02613767
Other Study ID Numbers 15161
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Nicholas Burd, University of Illinois at Urbana-Champaign
Study Sponsor University of Illinois at Urbana-Champaign
Collaborators Not Provided
Investigators
Principal Investigator: Nicholas A Burd, Ph.D Assistant Professor
PRS Account University of Illinois at Urbana-Champaign
Verification Date October 2016